What type of study is this?

This is a Cohort Study study (also classified as: Human Clinical Trial).

December 8, 2025BloodOpen Access

Real-world treatment patterns of elranatamab in patients with multiple myeloma in Japan: Findings from the EVEREST study

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis found dosing patterns in Japanese patients with multiple myeloma, indicating outpatient administration is common.

Median age of included patients was 74 years, and 54.5% were female.
Majority followed the step-up dosing schedule with inpatient administration noted during initial therapy.
Analysis of hospital claims data from the Japan Medical Data Vision database highlights treatment approaches.
Findings suggest outpatient usage is prevalent during maintenance phases in this population.

Johnson et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis found dosing patterns in Japanese patients with multiple myeloma, indicating outpatient administration is common.

Median age of included patients was 74 years, and 54.5% were female.
Majority followed the step-up dosing schedule with inpatient administration noted during initial therapy.
Analysis of hospital claims data from the Japan Medical Data Vision database highlights treatment approaches.
Findings suggest outpatient usage is prevalent during maintenance phases in this population.

Johnson et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark